Kenneth Man
@kennethkcman.bsky.social
Lecturer @UCL | CStat, FHEA, FRSPH | #RxEpi | #ADHD | Exploring the world with data | Prenatal, Children & Mental health | Views are my own
Reposted by Kenneth Man
The fifth and final member of our OPERA 2025 shortlist, #WallisLau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use.
Read the full profile here: buff.ly/unZtqxW
The overall winner will be announced on Monday 30 June 2025 🏆
Read the full profile here: buff.ly/unZtqxW
The overall winner will be announced on Monday 30 June 2025 🏆
OPERA 2025: Wallis Lau
Wallis’s journey into pharmacy exemplifies how public health can greatly benefit from interprofessional research. Wallis began her career as a statistician before transitioning into…
pharmaceutical-journal.com
June 27, 2025 at 10:04 AM
The fifth and final member of our OPERA 2025 shortlist, #WallisLau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use.
Read the full profile here: buff.ly/unZtqxW
The overall winner will be announced on Monday 30 June 2025 🏆
Read the full profile here: buff.ly/unZtqxW
The overall winner will be announced on Monday 30 June 2025 🏆
Reposted by Kenneth Man
ADHD medication shortages are ongoing worldwide due to supply chain disruptions. If affected, speak with your healthcare provider about alternatives. Stay proactive for the best ADHD care!
Read more: timespan.eu/adhd-medicat...
By Andrew Yuen & @kennethkcman.bsky.social
#ADHD #MedicationShortage
Read more: timespan.eu/adhd-medicat...
By Andrew Yuen & @kennethkcman.bsky.social
#ADHD #MedicationShortage
Update on ADHD medication shortage - TIMESPAN
Global supply chain disruptions continue to affect the production and distribution of ADHD medications, including commonly prescribed treatments.
timespan.eu
May 30, 2025 at 7:18 AM
ADHD medication shortages are ongoing worldwide due to supply chain disruptions. If affected, speak with your healthcare provider about alternatives. Stay proactive for the best ADHD care!
Read more: timespan.eu/adhd-medicat...
By Andrew Yuen & @kennethkcman.bsky.social
#ADHD #MedicationShortage
Read more: timespan.eu/adhd-medicat...
By Andrew Yuen & @kennethkcman.bsky.social
#ADHD #MedicationShortage
New study in @bmj.com!
We find that gabapentinoid treatment not causally linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey.
We find that gabapentinoid treatment not causally linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey.
Treatment with gabapentinoids isn't directly associated with an increased risk of self-harm, finds this study.
However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients
www.bmj.com/content/389/...
However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients
www.bmj.com/content/389/...
May 1, 2025 at 10:01 AM
New study in @bmj.com!
We find that gabapentinoid treatment not causally linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey.
We find that gabapentinoid treatment not causally linked to increased self-harm risk. Risk is highest before and after treatment—not during. Close monitoring needed across the full treatment journey.
Reposted by Kenneth Man
🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth
➡ Full blog post: timespan.eu/healthcare-d...
➡ Full blog post: timespan.eu/healthcare-d...
January 29, 2025 at 1:39 PM
🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth
➡ Full blog post: timespan.eu/healthcare-d...
➡ Full blog post: timespan.eu/healthcare-d...